Merrimack Pharmaceuticals
MACK
#7998
Rank
C$0.32 B
Marketcap
$21.80
Share price
0.00%
Change (1 day)
10.27%
Change (1 year)

Earnings for Merrimack Pharmaceuticals (MACK)

Earnings in 2024 (TTM): -C$3.04 Million

According to Merrimack Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$3.14 Million a decrease over its 2022 earnings that were of -C$3.14 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Merrimack Pharmaceuticals from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$3.04 Million-3.3%
2023 -C$3.14 Million0.09%
2022 -C$3.14 Million-16.9%
2021 -C$3.77 Million-49.89%
2020 -C$7.53 Million-75.39%
2019 -C$30.57 Million-68.58%
2018 -C$97.26 Million-19.4%
2017 -C$0.13 Billion-36.46%
2016 -C$0.19 Billion2.54%
2015 -C$0.19 Billion96.78%
2014 -C$94.13 Million-45.44%
2013 -C$0.18 Billion
2010 -C$66.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$11.44 B-351,673.26%๐Ÿ‡ซ๐Ÿ‡ท France
-C$41.84 Million 1,185.48%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.28 Billion 8,269.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.32 Billion 9,523.90%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$59.25 Million 1,720.41%๐Ÿ‡บ๐Ÿ‡ธ USA